Creative Biolabs Expands Research Infrastructure to Accelerate Next-Generation Weight-Loss Drugs

New York, Wednesday, 11 March 2026.
As the lucrative weight-loss drug market surges, Creative Biolabs is expanding its metabolic research tools to accelerate the discovery of next-generation, multi-pathway obesity and diabetes treatments.